Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of ondansetron and amisulpride for prevention of postoperative nausea and vomiting in general abdominal surgeries
IRCT20210926052599N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ondansetron and amisulpride in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Islamic Azad University. Primary endpoint: Incidence of postoperative nausea and vomiting. Started Oct 2021; status: completed.
02
Drugs
ondansetronamisulpride
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20210926052599N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210926052599N1.